In advance of the New Jersey Drug Affordability Unit’s October 15 meeting and extended public comment period on its policy…
In advance of the New Jersey Drug Affordability Unit’s October 15 meeting and extended public comment period on its policy…
The 2027 Open Enrollment period is fast approaching! The 2027 Open Enrollment period for Medicare Advantage plans is October 15,…
The Trump Administration has finalized updates to the Transparency in Coverage (TiC) rule intended to make health care pricing…
Aimed Alliance submitted comments in response to Senator Ron Wyden’s “Health Coverage That Works for Everyone” initiative, urging Congress to…
AI companies developing autonomous clinical AI systems are increasingly advocating for a federal licensing framework rather than a state-by-state approach,…
A bipartisan group of federal lawmakers introduced the Doctor’s Not AI Act, which would the bill would limit AI to…
On August 28, 2026, Aimed Alliance submitted a letter supporting the SUSTAIN 340B Act, a bipartisan legislation to strengthen and…
Aimed Alliance has released new recommendations for reforming the federal 340B Drug Pricing Program and advancing state-based alternatives to strengthen…
On August 14, Aimed Alliance submitted a comment to the Senate Finance Committee’s Request for Information on Commonsense Policy Options…
A new Yale University study raises questions about how the Trump Administration’s proposed Medicare international reference pricing (IRP) models, GLOBE…